Hermes

Due: Jun 11, 2024

Description

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals to develop systemic drug delivery platforms for medical countermeasures (MCMs). The Hermes program is explicitly seeking transformative approaches enabling the development of delivery platforms with systemic biodistribution, exceptional endosomal escape efficiency, and minimal toxicity. Successful proposals will include a detailed description of the proposed delivery platform including 1) screening pipeline, 2) reporter system...

Eligible Applicants- Others

Additional Eligibility Information

All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information.:

Funding TypeCooperative AgreementCategories of Funding Activity- Science, Technology, and Research & DevelopmentOpportunity TypeDiscretionary

Grantor Emailhermesbaa@darpa.milOther Grantor InformaitonDr. Shannon Greene HermesBAA@darpa.mil

Additional informationSAM.gov Contract OpportunitiesSupporting Linkhttps://sam.gov/opp/68fe51044e5f4c588cb1aa0faae9cc12/view